Pembrolizumab + Idelalisib for Lung Cancer Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
- Status
- COMPLETED
- Phase
- PHASE2
Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries
- Status
- COMPLETED
- Phase
- PHASE4
Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD
- Status
- TERMINATED
- Phase
- PHASE2
Dosing Obese With Noxafil® Under a Trial (DONUT)
- Status
- COMPLETED
- Phase
- PHASE4
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)
- Status
- COMPLETED
- Phase
- PHASE3
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
- Status
- COMPLETED
- Phase
- PHASE1
MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)
- Status
- COMPLETED
- Phase
- PHASE2
PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2